{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-085442","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.232829+00:00","generated_at":"2026-05-19T10:46:29.064720+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Crinetics shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting","bullets":["Elected Class I directors R. Scott Struthers (69.6M for), Matthew K. Fust (67.6M for), and Rogério Vivaldi Coelho (68.9M for), each with ~3.6M broker non-votes.","Ratified BDO USA as independent auditor for FY2025: 88.7M for, 129K against, 59.7K abstentions, no broker non-votes.","Advisory vote approved named executive officer compensation: 82.7M for, 2.6M against, 20.9K abstentions, ~3.6M broker non-votes.","Approximately 95% of outstanding shares (88.9M shares) were present or represented by proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-085442","json":"https://secwatch.observer/filing/0000950170-25-085442.json","markdown":"https://secwatch.observer/filing/0000950170-25-085442.md","text":"https://secwatch.observer/filing/0000950170-25-085442.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000095017025085442/0000950170-25-085442-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000095017025085442/crnx-20250611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:46:29.064720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}